Intravenous Magnesium Sulphate Versus in Wetting solution in Counteracting Epinephrine Cardiac Adverse Events: Prospective Randomized controlled Trial.
Not Applicable
- Conditions
- Anaesthesia
- Registration Number
- PACTR202105734020705
- Lead Sponsor
- faculty of medicine Tanta University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 129
Inclusion Criteria
Adult patients of both genders
aged between 20 and 60 years.
Classified by American society of anesthesiologists (ASA) I or II
BMI 21-35 Kg/m2 who is preparing for abdominal liposuction procedure will be enrolled in our study.
Exclusion Criteria
Patients' refusal to participate
liposuction for other body part
body mass index =40
known renal or hepatic insufficiency, cardiac disorders
known allergy to study drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method evaluate the efficacy of intravenous versus wetting solution MgSO4 in counteracting epinephrine induced cardiac adverse events (e.g. tachyarrhythmia, and hypertension) as primary outcome
- Secondary Outcome Measures
Name Time Method evaluate the efficacy of intravenous versus wetting solution MgSO4on pain scores and total analgesic requirement as secondary outcome.